Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis

Yang,Xinwei; Qiu,Zhiquan; Ran,Rongzhen; Cui,Longjiu; Luo,Xiangji; Wu,Mengchao; Tan,Wei‑Feng; Jiang,Xiaoqing

doi:10.3892/ol.2018.9108

Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis

Authors:
- Xinwei Yang
- Zhiquan Qiu
- Rongzhen Ran
- Longjiu Cui
- Xiangji Luo
- Mengchao Wu
- Wei‑Feng Tan
- Xiaoqing Jiang
View Affiliations

Affiliations: Department of Biliary Surgery, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, P.R. China
Published online on: July 10, 2018 https://doi.org/10.3892/ol.2018.9108
Pages: 3593-3602
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There is not yet a consensus regarding a difference in prognosis for patients with hepatocellular carcinoma (HCC) with and without bile duct invasion (BDI). The present study aimed to clarify the prognostic importance of BDI on the short and long‑term outcome of patients with HCC who underwent surgical resection. The present study evaluated HCC with BDI, including peripheral microscopic biliary invasion and revealed that the prognosis of patients with BDI was poorer compared with those without BDI. It should be noted that peripheral BDI also had a negative impact on the prognosis of patients with HCC. The clinical prognosis assessment revealed that BDI should be considered when assigning a disease stage. BDI, either macroscopic or microscopic, indicated a poor prognosis in patients with HCC who underwent curative resection, however it was not a surgical contraindication. Macroscopic BDI and hyperbilirubinemia were significantly associated with a dismal prognosis, which should alert surgeons.

View Figures

View References

1	Lau W, Leung K, Leung TW, Liew CT, Chan MS, Yu SC and Li AK: A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg. 225:281–285. 1997. View Article : Google Scholar : PubMed/NCBI
2	Uchima-Koecklin H, Balderramo D and Cárdenas A: Bile duct hepatocellular carcinoma thrombi. Gastroenterol Hepatol. 35:326–329. 2012. View Article : Google Scholar : PubMed/NCBI
3	Ikenaga N, Chijiiwa K, Otani K, Ohuchida J, Uchiyama S and Kondo K: Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg. 13:492–497. 2009. View Article : Google Scholar : PubMed/NCBI
4	Hu XG, Mao W, Hong SY, Kim BW, Xu WG and Wang HJ: Surgical treatment for hepatocellular carcinoma with bile duct invasion. Ann Surg Treat Res. 90:139–146. 2016. View Article : Google Scholar : PubMed/NCBI
5	Oba A, Takahashi S, Kato Y, Gotohda N, Kinoshita T, Shibasaki H, Ikeda M and Konishi M: Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus. Anticancer Res. 34:4367–4372. 2014.PubMed/NCBI
6	Xiangji L, Weifeng T, Bin Y, Chen L, Xiaoqing J, Baihe Z, Feng S and Mengchao W: Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: Efficacy for criteria for different therapy modalities. Langenbecks Arch Surg. 394:1033–1039. 2009. View Article : Google Scholar : PubMed/NCBI
7	Yu XH, Xu LB, Liu C, Zhang R and Wang J: Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi. Dig Dis Sci. 56:252–259. 2011. View Article : Google Scholar : PubMed/NCBI
8	Yeh CN, Jan YY, Lee WC and Chen MF: Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg. 28:471–475. 2004. View Article : Google Scholar : PubMed/NCBI
9	Ha TY, Hwang S, Moon DB, Ahn CS, Kim KH, Song GW, Jung DH, Park GC, Park HW, Park YH, et al: Long-term survival analysis of liver transplantation for hepatocellular carcinoma with bile duct tumor thrombus. Transplant Proc. 46:774–777. 2014. View Article : Google Scholar : PubMed/NCBI
10	Wang YD, Xue HZ, Jiang QF, Shen Q, Wang LC, Zhang X, Lu B, Yu M and Li K: Surgical operation and re-operation for hepatocellular carcinoma with bile duct thrombosis. Chin Med J (Engl). 123:2163–2170. 2010.PubMed/NCBI
11	Shiomi M, Kamiya J, Nagino M, Uesaka K, Sano T, Hayakawa N, Kanai M, Yamamoto H and Nimura Y: Hepatocellular carcinoma with biliary tumor thrombi: Aggressive operative approach after appropriate preoperative management. Surgery. 129:692–698. 2001. View Article : Google Scholar : PubMed/NCBI
12	Qin LX, Ma ZC, Wu ZQ, Fan J, Zhou XD, Sun HC, Ye QH, Wang L and Tang ZY: Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: Experience of 34 patients. World J Gastroenterol. 10:1397–1401. 2004. View Article : Google Scholar : PubMed/NCBI
13	Peng SY, Wang JW, Liu YB, Cai XJ, Deng GL, Xu B and Li HJ: Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma. World J Surg. 28:43–46. 2004. View Article : Google Scholar : PubMed/NCBI
14	Yang XW, Yuan JM, Chen JY, Yang J, Gao QG, Yan XZ, Zhang BH, Feng S and Wu MC: The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer. BMC Cancer. 14:6522014. View Article : Google Scholar : PubMed/NCBI
15	International Union Against Cancer: TNM classification of malignant tumors. 7th edition. Wiley; New York: 2009
16	Charrez B, Qiao L and Hebbard L: Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. World J Gastroenterol. 22:2494–2502. 2016. View Article : Google Scholar : PubMed/NCBI
17	Batsis JA, Halfdanarson TR and Pitot H: Extra-hepatic hepatocellular carcinoma presenting as obstructive jaundice. Dig Liver Dis. 38:768–771. 2006. View Article : Google Scholar : PubMed/NCBI
18	Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N and Nakashima T: Hepatocellular carcinoma presenting as intrabile duct tumor growth: A clinicopathologic study of 24 cases. Cancer. 49:2144–2147. 1982. View Article : Google Scholar : PubMed/NCBI
19	Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
20	European Association for the study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
21	Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, et al: Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis. Clin Mol Hepatol. 22:160–167. 2016. View Article : Google Scholar : PubMed/NCBI
22	Minagawa M and Makuuchi M: Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol. 12:7561–7567. 2006. View Article : Google Scholar : PubMed/NCBI
23	Tan WF, Qiu ZQ, Yu Y, Ran RZ, Yi B, Lau WY, Liu C, Qiu YH, Feng FL, Wang JH, et al: Sorafenb extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation. Acta Pharmacol Sin. 31:1643–1648. 2010. View Article : Google Scholar : PubMed/NCBI
24	Pitt HA, Gomes AS, Lois JF, Mann LL, Deutsch LS and Longmire WP Jr: Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg. 201:545–553. 1985. View Article : Google Scholar : PubMed/NCBI
25	Yamamoto S, Hasegawa K, Inoue Y, Shindoh J, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M and Kokudo N: Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg. 261:e123–e125. 2015. View Article : Google Scholar : PubMed/NCBI
26	Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H and Gouma DJ: A meta-analysis on the efficacy of preoperative biliary drainage for the tumors causing obstructive jaundice. Ann Surg. 236:17–27. 2002. View Article : Google Scholar : PubMed/NCBI
27	Agarwal AK, Mandal S, Singh S, Bhojwani R, Sakhuja P and Uppal R: Biliary obstruction in gall bladder cancer is not sine qua non of inoperability. Ann Surg Oncol. 14:2831–2837. 2007. View Article : Google Scholar : PubMed/NCBI
28	Choi J, Ryu JK, Lee SH, Ahn DW, Hwang JH, Kim YT, Yoon YB and Han JK: Biliary drainage for obstructive jaundice caused by unresectable hepatocellular carcinoma: The endoscopic versus percutaneous approach. Hepatobiliary Pancreat Dis Int. 11:636–642. 2012. View Article : Google Scholar : PubMed/NCBI
29	Cho HC, Lee JK, Lee KH, Lee KT, Paik S, Choo SW, Do YS and Choo IW: Are endoscopic or percutaneous biliary drainage effective for obstructive jaundice caused by hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 23:224–231. 2011. View Article : Google Scholar : PubMed/NCBI
30	Noda T, Nagano H, Tomimaru Y, Murakami M, Wada H, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, Tanemura M, et al: Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery. Surgery. 149:371–377. 2011. View Article : Google Scholar : PubMed/NCBI
31	Chen C, Chen PJ, Yang PM, Huang GT, Lai MY, Tsang YM and Chen DS: Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol. 92:2257–2259. 1997.PubMed/NCBI
32	de Baère T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, El Din Gamal M, Letoublon C and Elias D: Adverse events during radiofrequency treatment of 582 hapatic tumors. AJR Am J Roentgenol. 181:695–700. 2003. View Article : Google Scholar : PubMed/NCBI
33	A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 28:751–755. 1998. View Article : Google Scholar : PubMed/NCBI
34	Chung H, Kudo M, Takahashi S, Hagiwara S, Sakaguchi Y, Inoue T, Minami Y, Ueshima K, Fukunaga T and Matsunaga T: Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification and Tokyo score. J Gastroenterol Hepatol. 23:445–452. 2008. View Article : Google Scholar : PubMed/NCBI